Tribunal rules in favor of appellant, clarifies valuation of physician samples under Central Excise Act

The Tribunal allowed the appeal, ruling in favor of the appellant in a case concerning the valuation of physician samples under the Central Excise Act, 1944. The Tribunal held that the valuation method adopted by the appellant, which differentiated physician samples from medicaments meant for retail sale, was correct. Relying on legal precedents, the Tribunal set aside the demand raised by the Department, emphasizing the distinction between physician samples and products intended for retail sale. The decision provided clarity on the valuation of physician samples for duty payment, ensuring adherence to established legal principles and consistency in excise law application.

---

---

Issues: Valuation of physician samples for duty payment under Central Excise Act, 1944

Issue 1: Valuation of physician samples
The appellant, engaged in manufacturing medicaments, sold physician samples to pharmaceutical companies without affixing MRP as these were not meant for retail sale. The Department contended that the valuation method adopted by the appellant was incorrect. A show-cause notice was issued, alleging that the value of physician samples should have been determined partly under Section 4A based on MRP and partly under Section 4 based on transaction value. The original authority confirmed the demand, leading to the appeal.

Analysis:
The appellant's argument was that physician samples were not meant for retail sale and were sold to pharmaceutical companies against a price agreed upon, not free of cost. The appellant differentiated the physician samples from the medicaments meant for retail sale by using different packaging and labeling. The Tribunal referred to a previous order in the appellant's own case and a judgment in CC Vs. Sidmak Laboratories (India) Ltd., upheld by the Supreme Court. Relying on these precedents, the Tribunal held that the demand was unsustainable and set aside the impugned order. The appeal was allowed with consequential reliefs.

Conclusion:
The Tribunal's decision was based on the interpretation of the valuation method for physician samples under the Central Excise Act, 1944. By applying established legal principles and precedents, the Tribunal ruled in favor of the appellant, emphasizing the distinction between physician samples and medicaments meant for retail sale. The judgment provided clarity on the valuation of physician samples for duty payment, ensuring consistency in the application of excise laws.

---